The TNF-family cytokine TL1A: From lymphocyte costimulator to disease co-conspirator

Journal of Leukocyte Biology

Volumn 98, Issue 3, 2015, Pages 333-345

  Richard, Arianne C ^a,b   Ferdinand, John R ^a,c   Meylan, Françoise ^a   Hayes, Erika T ^a   Gabay, Odile ^a   Siegel, Richard M ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Autoimmune disease; DR3

Indexed keywords

DR3 PROTEIN; TUMOR NECROSIS FACTOR LIKE FACTOR 1A; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; DEATH RECEPTOR; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

AUTOIMMUNE DISEASE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL STIMULATION; CELLS BY BODY ANATOMY; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; INFLAMMATORY BOWEL DISEASE; LEPROSY; LYMPHOID CELL; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; ANIMAL; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; HUMANS; LYMPHOCYTE ACTIVATION; RECEPTORS, DEATH DOMAIN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 84940654026     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3RI0315-095R     Document Type: Review

References (127)

1. Bodmer, J. L., Schneider, P., Tschopp, J. (2002) The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27, 19-26.
2. Screaton, G. R., Xu, X. N., Olsen, A. L., Cowper, A. E., Tan, R., McMichael, A. J., Bell, J. I. (1997) LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc. Natl. Acad. Sci. U. S. A. 94, 4615-4619.
3. Chinnaiyan, A. M., O'Rourke, K., Yu, G. L., Lyons, R. H., Garg, M., Duan, D. R., Xing, L., Gentz, R., Ni, J., Dixit, V. M. (1996) Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274, 990-992.
4. Kitson, J., Raven, T., Jiang, Y. P., Goeddel, D. V., Giles, K. M., Pun, K. T., Grinham, C. J., Brown, R., Farrow, S. N. (1996) A death-domaincontaining receptor that mediates apoptosis. Nature 384, 372-375.
5. Bodmer, J. L., Burns, K., Schneider, P., Hofmann, K., Steiner, V., Thome, M., Bornand, T., Hahne, M., Schröter, M., Becker, K., Wilson, A., French, L. E., Browning, J. L., MacDonald, H. R., Tschopp, J. (1997) TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 6, 79-88.
6. Marsters, S. A., Sheridan, J. P., Donahue, C. J., Pitti, R. M., Gray, C. L., Goddard, A. D., Bauer, K. D., Ashkenazi, A. (1996) Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB. Curr. Biol. 6, 1669-1676.
7. Zhai, Y., Ni, J., Jiang, G. W., Lu, J., Xing, L., Lincoln, C., Carter, K. C., Janat, F., Kozak, D., Xu, S., Rojas, L., Aggarwal, B. B., Ruben, S., Li, L. Y., Gentz, R., Yu, G. L. (1999) VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. FASEB J. 13, 181-189.
8. Yue, T. L., Ni, J., Romanic, A. M., Gu, J. L., Keller, P., Wang, C., Kumar, S., Yu, G. L., Hart, T. K., Wang, X., Xia, Z., DeWolf, W. E., Jr., Feuerstein, G. Z. (1999) TL1, a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells: involvement of activation of stress protein kinases (stress-activated protein kinase and p38 mitogen-activated protein kinase) and caspase-3-like protease. J. Biol. Chem. 274, 1479-1486.
9. Migone, T. S., Zhang, J., Luo, X., Zhuang, L., Chen, C., Hu, B., Hong, J. S., Perry, J. W., Chen, S. F., Zhou, J. X., Cho, Y. H., Ullrich, S., Kanakaraj, P., Carrell, J., Boyd, E., Olsen, H. S., Hu, G., Pukac, L., Liu, D., Ni, J., Kim, S., Gentz, R., Feng, P., Moore, P. A., Ruben, S. M., Wei, P. (2002) TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16, 479-492.
10. Borysenko, C. W., Furey, W. F., Blair, H. C. (2005) Comparative modeling of TNFRSF25 (DR3) predicts receptor destabilization by a mutation linked to rheumatoid arthritis. Biochem. Biophys. Res. Commun. 328, 794-799.
11. Yu, K. Y., Kwon, B., Ni, J., Zhai, Y., Ebner, R., Kwon, B. S. (1999) A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J. Biol. Chem. 274, 13733-13736.
12. Pitti, R. M., Marsters, S. A., Lawrence, D. A., Roy, M., Kischkel, F. C., Dowd, P., Huang, A., Donahue, C. J., Sherwood, S. W., Baldwin, D. T., Godowski, P. J., Wood, W. I., Gurney, A. L., Hillan, K. J., Cohen, R. L., Goddard, A. D., Botstein, D., Ashkenazi, A. (1998) Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396, 699-703.
13. Bai, C., Connolly, B., Metzker, M. L., Hilliard, C. A., Liu, X., Sandig, V., Soderman, A., Galloway, S. M., Liu, Q., Austin, C. P., Caskey, C. T. (2000) Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a fourgene cluster. Proc. Natl. Acad. Sci. U. S. A. 97, 1230-1235.
14. You, R. I., Chang, Y. C., Chen, P. M., Wang, W. S., Hsu, T. L., Yang, C. Y., Lee, C. T., Hsieh, S. L. (2008) Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3). Blood 111, 1480-1488.
15. Zhan, C., Patskovsky, Y., Yan, Q., Li, Z., Ramagopal, U., Cheng, H., Brenowitz, M., Hui, X., Nathenson, S. G., Almo, S. C. (2011) Decoy strategies: the structure of TL1A:DcR3 complex. Structure 19, 162-171.
16. Hsu, T. L., Wu, Y. Y., Chang, Y. C., Yang, C. Y., Lai, M. Z., Su, W. B., Hsieh, S. L. (2005) Attenuation of Th1 response in decoy receptor 3 transgenic mice. J. Immunol. 175, 5135-5145.
17. Sung, H. H., Juang, J. H., Lin, Y. C., Kuo, C. H., Hung, J. T., Chen, A., Chang, D. M., Chang, S. Y., Hsieh, S. L., Sytwu, H. K. (2004) Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice. J. Exp. Med. 199, 1143-1151.
18. Chung, J. Y., Park, Y. C., Ye, H., Wu, H. (2002) All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J. Cell Sci. 115, 679-688.
19. Wu, C. J., Conze, D. B., Li, T., Srinivasula, S. M., Ashwell, J. D. (2006) Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation [letter]. . [corrected] Nat. Cell Biol. 8, 398-406.
20. Wen, L., Zhuang, L., Luo, X., Wei, P. (2003) TL1A-induced NF-κB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells. J. Biol. Chem. 278, 39251-39258.
21. Micheau, O., Tschopp, J. (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181-190.
22. Declercq, W., Vanden Berghe, T., Vandenabeele, P. (2009) RIP kinases at the crossroads of cell death and survival. Cell 138, 229-232.
23. Meylan, F., Davidson, T. S., Kahle, E., Kinder, M., Acharya, K., Jankovic, D., Bundoc, V., Hodges, M., Shevach, E. M., Keane-Myers, A., Wang, E. C., Siegel, R. M. (2008) The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 29, 79-89.
24. Fang, L., Adkins, B., Deyev, V., Podack, E. R. (2008) Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation. J. Exp. Med. 205, 1037-1048.
25. Buchan, S. L., Taraban, V. Y., Slebioda, T. J., James, S., Cunningham, A. F., Al-Shamkhani, A. (2012) Death receptor 3 is essential for generating optimal protective CD4+ T-cell immunity against Salmonella. Eur. J. Immunol. 42, 580-588.
26. Prehn, J. L., Thomas, L. S., Landers, C. J., Yu, Q. T., Michelsen, K. S., Targan, S. R. (2007) The T cell costimulator TL1A is induced by FcγR signaling in human monocytes and dendritic cells. J. Immunol. 178, 4033-4038.
27. Shih, D. Q., Kwan, L. Y., Chavez, V., Cohavy, O., Gonsky, R., Chang, E. Y., Chang, C., Elson, C. O., Targan, S. R. (2009) Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells. Eur. J. Immunol. 39, 3239-3250.
28. Longman, R. S., Diehl, G. E., Victorio, D. A., Huh, J. R., Galan, C., Miraldi, E. R., Swaminath, A., Bonneau, R., Scherl, E. J., Littman, D. R. (2014) CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J. Exp. Med. 211, 1571-1583.
29. Al-Lamki, R. S., Wang, J., Tolkovsky, A. M., Bradley, J. A., Griffin, J. L., Thiru, S., Wang, E. C., Bolton, E., Min, W., Moore, P., Pober, J. S., Bradley, J. R. (2008) TL1A both promotes and protects from renal inflammation and injury. J. Am. Soc. Nephrol. 19, 953-960.
30. Twohig, J. P., Roberts, M. I., Gavalda, N., Rees-Taylor, E. L., Giralt, A., Adams, D., Brooks, S. P., Bull, M. J., Calder, C. J., Cuff, S., Yong, A. A., Alberch, J., Davies, A., Dunnett, S. B., Tolkovsky, A. M., Wang, E. C. (2010) Age-dependent maintenance of motor control and corticostriatal innervation by death receptor 3. J. Neurosci. 30, 3782-3792.
31. Cavallini, C., Lovato, O., Bertolaso, A., Pacelli, L., Zoratti, E., Zanolin, E., Krampera, M., Zamò, A., Tecchio, C., Cassatella, M. A., Pizzolo, G., Scupoli, M. T. (2013) The TNF-family cytokine TL1A inhibits proliferation of human activated B cells. PLoS One 8, e60136.
32. Wang, X., Hu, Y., Charpentier, T., Lamarre, A., Qi, S., Wu, J., Luo, H. (2013) TNF-like ligand 1A (TL1A) gene knockout leads to ameliorated collagen-induced arthritis in mice: implication of TL1A in humoral immune responses. J. Immunol. 191, 5420-5429.
33. Twohig, J. P., Marsden, M., Cuff, S. M., Ferdinand, J. R., Gallimore, A. M., Perks, W. V., Al-Shamkhani, A., Humphreys, I. R., Wang, E. C. (2012) The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4+ and CD8+⁺ T-cell immunity. FASEB J. 26, 3575-3586.
34. Pappu, B. P., Borodovsky, A., Zheng, T. S., Yang, X., Wu, P., Dong, X., Weng, S., Browning, B., Scott, M. L., Ma, L., Su, L., Tian, Q., Schneider, P., Flavell, R. A., Dong, C., Burkly, L. C. (2008) TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J. Exp. Med. 205, 1049-1062.
35. Richard, A. C., Tan, C., Hawley, E. T., Gomez-Rodriguez, J., Goswami, R., Yang, X. P., Cruz, A. C., Penumetcha, P., Hayes, E. T., Pelletier, M., Gabay, O., Walsh, M., Ferdinand, J. R., Keane-Myers, A., Choi, Y., O'Shea, J. J., Al-Shamkhani, A., Kaplan, M. H., Gery, I., Siegel, R. M., Meylan, F. (2015) The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells. J. Immunol. 194, 3567-3582.
36. Slebioda, T. J., Rowley, T. F., Ferdinand, J. R., Willoughby, J. E., Buchan, S. L., Taraban, V. Y., Al-Shamkhani, A. (2011) Triggering of TNFRSF25 promotes CD8+ T-cell responses and anti-tumor immunity. Eur. J. Immunol. 41, 2606-2611.
37. Cohavy, O., Shih, D. Q., Doherty, T. M., Ware, C. F., Targan, S. R. (2011) Cd161 defines effector T cells that express light and respond to Tl1a-Dr3 signaling. Eur. J. Microbiol. Immunol. (Bp.) 1, 70-79.
38. Taraban, V. Y., Ferdinand, J. R., Al-Shamkhani, A. (2011) Expression of TNFRSF25 on conventional T cells and Tregs. J. Clin. Invest. 121, 463-464, author reply 465.
39. Schreiber, T. H., Wolf, D., Tsai, M. S., Chirinos, J., Deyev, V. V., Gonzalez, L., Malek, T. R., Levy, R. B., Podack, E. R. (2010) Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation. J. Clin. Invest. 120, 3629-3640.
40. Papadakis, K. A., Prehn, J. L., Landers, C., Han, Q., Luo, X., Cha, S. C., Wei, P., Targan, S. R. (2004) TL1A synergizes with IL-12 and IL-18 to enhance IFN-γ production in human T cells and NK cells. J. Immunol. 172, 7002-7007.
41. Meylan, F., Hawley, E. T., Barron, L., Barlow, J. L., Penumetcha, P., Pelletier, M., Sciumè, G., Richard, A. C., Hayes, E. T., Gomez-Rodriguez, J., Chen, X., Paul, W. E., Wynn, T. A., McKenzie, A. N., Siegel, R. M. (2014) The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells. Mucosal Immunol. 7, 958-968.
42. Yu, X., Pappu, R., Ramirez-Carrozzi, V., Ota, N., Caplazi, P., Zhang, J., Yan, D., Xu, M., Lee, W. P., Grogan, J. L. (2014) TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers. Mucosal Immunol.. 7, 730-740.
43. Hedl, M., Abraham, C. (2014) A TNFSF15 disease-risk polymorphism increases pattern-recognition receptor-induced signaling through caspase-8-induced IL-1. Proc. Natl. Acad. Sci. U. S. A. 111, 13451-13456.
44. Al-Lamki, R. S., Wang, J., Thiru, S., Pritchard, N. R., Bradley, J. A., Pober, J. S., Bradley, J. R. (2003) Expression of silencer of death domains and death-receptor-3 in normal human kidney and in rejecting renal transplants. Am. J. Pathol. 163, 401-411.
45. Wang, E. C., Kitson, J., Thern, A., Williamson, J., Farrow, S. N., Owen, M. J. (2001) Genomic structure, expression, and chromosome mapping of the mouse homologue for the WSL-1 (DR3, Apo3, TRAMP, LARD, TR3, TNFRSF12) gene. Immunogenetics 53, 59-63.
46. Bamias, G., Martin III, C., Marini, M., Hoang, S., Mishina, M., Ross, W. G., Sachedina, M. A., Friel, C. M., Mize, J., Bickston, S. J., Pizarro, T. T., Wei, P., Cominelli, F. (2003) Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J. Immunol. 171, 4868-4874.
47. Heidemann, S. C., Chavez, V., Landers, C. J., Kucharzik, T., Prehn, J. L., Targan, S. R. (2010) TL1A selectively enhances IL-12/IL-18-induced NK cell cytotoxicity against NK-resistant tumor targets. J. Clin. Immunol. 30, 531-538.
48. Walker, J. A., McKenzie, A. N. (2013) Development and function of group 2 innate lymphoid cells. Curr. Opin. Immunol. 25, 148-155.
49. Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., Koyasu, S., Locksley, R. M., McKenzie, A. N., Mebius, R. E., Powrie, F., Vivier, E. (2013) Innate lymphoid cells-a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145-149.
50. Saruta, M., Michelsen, K. S., Thomas, L. S., Yu, Q. T., Landers, C. J., Targan, S. R. (2009) TLR8-mediated activation of human monocytes inhibits TL1A expression. Eur. J. Immunol. 39, 2195-2202.
51. McLaren, J. E., Calder, C. J., McSharry, B. P., Sexton, K., Salter, R. C., Singh, N. N., Wilkinson, G. W., Wang, E. C., Ramji, D. P. (2010) The TNF-like protein 1A-death receptor 3 pathway promotes macrophage foam cell formation in vitro. J. Immunol. 184, 5827-5834.
52. Ashlin, T. G., Kwan, A. P., Ramji, D. P. (2013) Regulation of ADAMTS-1, -4 and -5 expression in human macrophages: differential regulation by key cytokines implicated in atherosclerosis and novel synergism between TL1A and IL-17. Cytokine 64, 234-242.
53. Bull, M. J., Williams, A. S., Mecklenburgh, Z., Calder, C. J., Twohig, J. P., Elford, C., Evans, B. A., Rowley, T. F., Slebioda, T. J., Taraban, V. Y., Al- Shamkhani, A., Wang, E. C. (2008) The death receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis. J. Exp. Med. 205, 2457-2464.
54. Bruce, A. J., Boling, W., Kindy, M. S., Peschon, J., Kraemer, P. J., Carpenter, M. K., Holtsberg, F. W., Mattson, M. P. (1996) Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 2, 788-794.
55. Jin, S., Chin, J., Seeber, S., Niewoehner, J., Weiser, B., Beaucamp, N., Woods, J., Murphy, C., Fanning, A., Shanahan, F., Nally, K., Kajekar, R., Salas, A., Planell, N., Lozano, J., Panes, J., Parmar, H., DeMartino, J., Narula, S., Thomas-Karyat, D. A. (2013) TL1A/TNFSF15 directly induces proinflammatory cytokines, including TNFα, from CD3+CD161+ T cells to exacerbate gut inflammation. Mucosal Immunol. 6, 886-899.
56. Reichwald, K., Jørgensen, T. Z., Skov, S. (2014) TL1A increases expression of CD25, LFA-1, CD134 and CD154, and induces IL-22 and GM-CSF production from effector CD4 T-cells. PLoS One 9, e105627.
57. Yao, J. J., Zhang, M., Miao, X. H., Zhao, P., Zhu, S. Y., Ding, H., Qi, Z. T. (2006) Isoform of vascular endothelial cell growth inhibitor (VEGI72- 251) increases interleukin-2 production by activation of T lymphocytes. Acta Biochim. Biophys. Sin. (Shanghai) 38, 249-253.
58. Jones, G. W., Stumhofer, J. S., Foster, T., Twohig, J. P., Hertzog, P., Topley, N., Williams, A. S., Hunter, C. A., Jenkins, B. J., Wang, E. C., Jones, S. A. (2011) Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation. FASEB J. 25, 409-419.
59. Prehn, J. L., Mehdizadeh, S., Landers, C. J., Luo, X., Cha, S. C., Wei, P., Targan, S. R. (2004) Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation. Clin. Immunol. 112, 66-77.
60. Papadakis, K. A., Zhu, D., Prehn, J. L., Landers, C., Avanesyan, A., Lafkas, G., Targan, S. R. (2005) Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes. J. Immunol. 174, 4985-4990.
61. Holmkvist, P., Roepstorff, K., Uronen-Hansson, H., Sandén, C., Gudjonsson, S., Patschan, O., Grip, O., Marsal, J., Schmidtchen, A., Hornum, L., Erjefält, J. S., Håkansson, K., Agace, W. W. (2015) A major population of mucosal memory CD4 T cells, coexpressing IL-18Rα and DR3, display innate lymphocyte functionality. Mucosal Immunol. 8, 545-558.
62. Laurence, A., Tato, C. M., Davidson, T. S., Kanno, Y., Chen, Z., Yao, Z., Blank, R. B., Meylan, F., Siegel, R., Hennighausen, L., Shevach, E. M., O'shea, J. J. (2007) Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371-381.
63. Kamada, N., Hisamatsu, T., Honda, H., Kobayashi, T., Chinen, H., Takayama, T., Kitazume, M. T., Okamoto, S., Koganei, K., Sugita, A., Kanai, T., Hibi, T. (2010) TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease. Inflamm. Bowel Dis. 16, 568-575.
64. Takedatsu, H., Michelsen, K. S., Wei, B., Landers, C. J., Thomas, L. S., Dhall, D., Braun, J., Targan, S. R. (2008) TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and Thelper 17 activation. Gastroenterology 135, 552-567.
65. Taraban, V. Y., Slebioda, T. J., Willoughby, J. E., Buchan, S. L., James, S., Sheth, B., Smyth, N. R., Thomas, G. J., Wang, E. C., Al-Shamkhani, A. (2011) Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia. Mucosal Immunol. 4, 186-196.
66. Meylan, F., Song, Y. J., Fuss, I., Villarreal, S., Kahle, E., Malm, I. J., Acharya, K., Ramos, H. L., Lo, L., Mentink-Kane, M. M., Wynn, T. A., Migone, T. S., Strober, W., Siegel, R. M. (2011) The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation. Mucosal Immunol. 4, 172-185.
67. Schmitt, E., Beuscher, H. U., Huels, C., Monteyne, P., van Brandwijk, R., van Snick, J., Ruede, E. (1991) IL-1 serves as a secondary signal for IL-9 expression. J. Immunol. 147, 3848-3854.
68. Schmitt, E., Germann, T., Goedert, S., Hoehn, P., Huels, C., Koelsch, S., Kühn, R., Müller, W., Palm, N., Rüde, E. (1994) IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-β and IL-4, and is inhibited by IFN-gamma. J. Immunol. 153, 3989-3996.
69. Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B., Wilhelm, C., Stockinger, B. (2008) Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9, 1341-1346.
70. Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R. A., Mitsdoerffer, M., Strom, T. B., Elyaman, W., Ho, I. C., Khoury, S., Oukka, M., Kuchroo, V. K. (2008) IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp32 effector T cells. Nat. Immunol. 9, 1347-1355.
71. Staudt, V., Bothur, E., Klein, M., Lingnau, K., Reuter, S., Grebe, N., Gerlitzki, B., Hoffmann, M., Ulges, A., Taube, C., Dehzad, N., Becker, M., Stassen, M., Steinborn, A., Lohoff, M., Schild, H., Schmitt, E., Bopp, T. (2010) Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33, 192-202.
72. Chang, H. C., Sehra, S., Goswami, R., Yao, W., Yu, Q., Stritesky, G. L., Jabeen, R., McKinley, C., Ahyi, A. N., Han, L., Nguyen, E. T., Robertson, M. J., Perumal, N. B., Tepper, R. S., Nutt, S. L., Kaplan, M. H. (2010) The transcription factor PU.1 is required for the development of IL-9- producing T cells and allergic inflammation. Nat. Immunol. 11, 527-534.
73. Yao, W., Tepper, R. S., Kaplan, M. H. (2011) Predisposition to the development of IL-9-secreting T cells in atopic infants. J. Allergy Clin. Immunol. 128, 1357-1360.e5.
74. Putheti, P., Awasthi, A., Popoola, J., Gao, W., Strom, T. B. (2010) Human CD4 memory T cells can become CD4+IL-9+ T cells. PLoS One 5, e8706.
75. Xiao, X., Balasubramanian, S., Liu, W., Chu, X., Wang, H., Taparowsky, E. J., Fu, Y. X., Choi, Y., Walsh, M. C., Li, X. C. (2012) OX40 signaling favors the induction of TH9 cells and airway inflammation. Nat. Immunol. 13, 981-990.
76. Halim, T. Y., Steer, C. A., Mathä, L., Gold, M. J., Martinez-Gonzalez, I., McNagny, K. M., McKenzie, A. N., Takei, F. (2014) Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cellmediated allergic lung inflammation. Immunity 40, 425-435.
77. Oliphant, C. J., Hwang, Y. Y., Walker, J. A., Salimi, M., Wong, S. H., Brewer, J. M., Englezakis, A., Barlow, J. L., Hams, E., Scanlon, S. T., Ogg, G. S., Fallon, P. G., McKenzie, A. N. (2014) MHCII-mediated dialog between group 2 innate lymphoid cells and CD4+ T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 41, 283-295.
78. Wang, E. C., Newton, Z., Hayward, O. A., Clark, S. R., Collins, F., Perks, W. V., Singh, R. K., Twohig, J. P., Williams, A. S. (2014) Regulation of early cartilage destruction in inflammatory arthritis by death receptor 3. Arthritis Rheumatol. 66, 2762-2772.
79. Bamias, G., Mishina, M., Nyce, M., Ross, W. G., Kollias, G., Rivera-Nieves, J., Pizarro, T. T., Cominelli, F. (2006) Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Proc. Natl. Acad. Sci. U. S. A. 103, 8441-8446.
80. Zhang, J., Wang, X., Fahmi, H., Wojcik, S., Fikes, J., Yu, Y., Wu, J., Luo, H. (2009) Role of TL1A in the pathogenesis of rheumatoid arthritis. J. Immunol. 183, 5350-5357.
81. Cassatella, M. A., Pereira-da-Silva, G., Tinazzi, I., Facchetti, F., Scapini, P., Calzetti, F., Tamassia, N., Wei, P., Nardelli, B., Roschke, V., Vecchi, A., Mantovani, A., Bambara, L. M., Edwards, S. W., Carletto, A. (2007) Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis. [corrected]. J. Immunol. 178, 7325-7333.
82. Bamias, G., Kaltsa, G., Siakavellas, S. I., Gizis, M., Margantinis, G., Zampeli, E., Vafiadis-Zoumboulis, I., Michopoulos, S., Daikos, G. L., and Ladas, S. D. (2012) Differential expression of the TL1A/DcR3 system of TNF/TNFR-like proteins in large vs. small intestinal Crohn's disease. Dig. Liver Dis. 44, 30-36.
83. Yamazaki, K., McGovern, D., Ragoussis, J., Paolucci, M., Butler, H., Jewell, D., Cardon, L., Takazoe, M., Tanaka, T., Ichimori, T., Saito, S., Sekine, A., Iida, A., Takahashi, A., Tsunoda, T., Lathrop, M., Nakamura, Y. (2005) Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum. Mol. Genet. 14, 3499-3506.
84. Okada, Y., Yamazaki, K., Umeno, J., Takahashi, A., Kumasaka, N., Ashikawa, K., Aoi, T., Takazoe, M., Matsui, T., Hirano, A., Matsumoto, T., Kamatani, N., Nakamura, Y., Yamamoto, K., Kubo, M. (2011) HLACw* 1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease. Gastroenterology. 141, 864-871.e1-5.
85. Yamazaki, K., Umeno, J., Takahashi, A., Hirano, A., Johnson, T. A., Kumasaka, N., Morizono, T., Hosono, N., Kawaguchi, T., Takazoe, M., Yamada, T., Suzuki, Y., Tanaka, H., Motoya, S., Hosokawa, M., Arimura, Y., Shinomura, Y., Matsui, T., Matsumoto, T., Iida, M., Tsunoda, T., Nakamura, Y., Kamatani, N., Kubo, M. (2013) A genome-wide association study identifies 2 susceptibility Loci for Crohn's disease in a Japanese population. Gastroenterology 144, 781-788.
86. Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Schumm, L. P., Sharma, Y., Anderson, C. A., Essers, J., Mitrovic, M., Ning, K., Cleynen, I., Theatre, E., Spain, S. L., Raychaudhuri, S., Goyette, P., Wei, Z., Abraham, C., Achkar, J. P., Ahmad, T., Amininejad, L., Ananthakrishnan, A. N., Andersen, V., Andrews, J. M., Baidoo, L., Balschun, T., Bampton, P. A., Bitton, A., Boucher, G., Brand, S., Büning, C., Cohain, A., Cichon, S., D'Amato, M., De Jong, D., Devaney, K. L., Dubinsky, M., Edwards, C., Ellinghaus, D., Ferguson, L. R., Franchimont, D., Fransen, K., Gearry, R., Georges, M., Gieger, C., Glas, J., Haritunians, T., Hart, A., Hawkey, C., Hedl, M., Hu, X., Karlsen, T. H., Kupcinskas, L., Kugathasan, S., Latiano, A., Laukens, D., Lawrance, I. C., Lees, C. W., Louis, E., Mahy, G., Mansfield, J., Morgan, A. R., Mowat, C., Newman, W., Palmieri, O., Ponsioen, C. Y., Potocnik, U., Prescott, N. J., Regueiro, M., Rotter, J. I., Russell, R. K., Sanderson, J. D., Sans, M., Satsangi, J., Schreiber, S., Simms, L. A., Sventoraityte, J., Targan, S. R., Taylor, K. D., Tremelling, M., Verspaget, H. W., De Vos, M., Wijmenga, C., Wilson, D. C., Winkelmann, J., Xavier, R. J., Zeissig, S., Zhang, B., Zhang, C. K., Zhao, H., Silverberg, M. S., Annese, V., Hakonarson, H., Brant, S. R., Radford-Smith, G., Mathew, C. G., Rioux, J. D., Schadt, E. E., Daly, M. J., Franke, A., Parkes, M., Vermeire, S., Barrett, J. C., Cho, J. H.; International IBD Genetics Consortium (IIBDGC). (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124.
87. Song, L., Zhou, R., Huang, S., Zhou, F., Xu, S., Wang, W., Yi, F., Wang, X., Xia, B. (2013) High intestinal and systemic levels of interleukin-23/ T-helper 17 pathway in Chinese patients with inflammatory bowel disease. Mediators Inflamm. 2013, 425915.
88. Bamias, G., Kaltsa, G., Siakavellas, S. I., Papaxoinis, K., Zampeli, E., Michopoulos, S., Zouboulis-Vafiadis, I., Ladas, S. D. (2010) High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis. Clin. Immunol. 137, 242-249.
89. Sun, X., Zhao, J., Liu, R., Jia, R., Sun, L., Li, X., Li, Z. (2013) Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis. Scand. J. Rheumatol. 42, 97-101.
90. Bamias, G., Siakavellas, S. I., Stamatelopoulos, K. S., Chryssochoou, E., Papamichael, C., Sfikakis, P. P. (2008) Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis. Clin. Immunol. 129, 249-255.
91. Xiu, Z., Shen, H., Tian, Y., Xia, L., Lu, J. (2015) Serum and synovial fluid levels of tumor necrosis factor-like ligand 1A and decoy receptor 3 in rheumatoid arthritis. Cytokine 72, 185-189.
92. Bamias, G., Stamatelopoulos, K., Zampeli, E., Protogerou, A., Sigala, F., Papamichael, C., Christopoulos, P., Kitas, G. D., Sfikakis, P. P. (2013) Circulating levels of TNF-like cytokine 1A correlate with the progression of atheromatous lesions in patients with rheumatoid arthritis. Clin. Immunol. 147, 144-150.
93. Bamias, G., Evangelou, K., Vergou, T., Tsimaratou, K., Kaltsa, G., Antoniou, C., Kotsinas, A., Kim, S., Gorgoulis, V., Stratigos, A. J., Sfikakis, P. P. (2011) Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions. Exp. Dermatol. 20, 725-731.
94. Li, L., Fu, L., Lu, Y., Wang, W., Liu, H., Li, F., Chen, T. (2014) TNF-like ligand 1A is associated with the pathogenesis of psoriasis vulgaris and contributes to IL-17 production in PBMCs. Arch. Dermatol. Res. 306, 927-932.
95. Aiba, Y., Harada, K., Komori, A., Ito, M., Shimoda, S., Nakamura, H., Nagaoka, S., Abiru, S., Migita, K., Ishibashi, H., Nakanuma, Y., Nishida, N., Kawashima, M., Tokunaga, K., Yatsuhashi, H., Nakamura, M. (2014) Systemic and local expression levels of TNF-like ligand 1A and its decoy receptor 3 are increased in primary biliary cirrhosis. Liver Int. 34, 679-688.
96. Nakamura, M., Nishida, N., Kawashima, M., Aiba, Y., Tanaka, A., Yasunami, M., Nakamura, H., Komori, A., Nakamuta, M., Zeniya, M., Hashimoto, E., Ohira, H., Yamamoto, K., Onji, M., Kaneko, S., Honda, M., Yamagiwa, S., Nakao, K., Ichida, T., Takikawa, H., Seike, M., Umemura, T., Ueno, Y., Sakisaka, S., Kikuchi, K., Ebinuma, H., Yamashiki, N., Tamura, S., Sugawara, Y., Mori, A., Yagi, S., Shirabe, K., Taketomi, A., Arai, K., Monoe, K., Ichikawa, T., Taniai, M., Miyake, Y., Kumagi, T., Abe, M., Yoshizawa, K., Joshita, S., Shimoda, S., Honda, K., Takahashi, H., Hirano, K., Takeyama, Y., Harada, K., Migita, K., Ito, M., Yatsuhashi, H., Fukushima, N., Ota, H., Komatsu, T., Saoshiro, T., Ishida, J., Kouno, H., Kouno, H., Yagura, M., Kobayashi, M., Muro, T., Masaki, N., Hirata, K., Watanabe, Y., Nakamura, Y., Shimada, M., Hirashima, N., Komeda, T., Sugi, K., Koga, M., Ario, K., Takesaki, E., Maehara, Y., Uemoto, S., Kokudo, N., Tsubouchi, H., Mizokami, M., Nakanuma, Y., Tokunaga, K., Ishibashi, H. (2012) Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am. J. Hum. Genet. 91, 721-728.
97. Konsta, M., Bamias, G., Tektonidou, M. G., Christopoulos, P., Iliopoulos, A., Sfikakis, P. P. (2013) Increased levels of soluble TNF-like cytokine 1A in ankylosing spondylitis. Rheumatology (Oxford) 52, 448-451.
98. Kim, W. J., Kang, Y. J., Suk, K., Park, J. E., Kwon, B. S., Lee, W. H. (2008) Comparative analysis of the expression patterns of various TNFSF/ TNFRSF in atherosclerotic plaques. Immunol. Invest. 37, 359-373.
99. Funke, B., Autschbach, F., Kim, S., Lasitschka, F., Strauch, U., Rogler, G., Gdynia, G., Li, L., Gretz, N., Macher-Goeppinger, S., Sido, B., Schirmacher, P., Meuer, S. C., Roth, W. (2009) Functional characterisation of decoy receptor 3 in Crohn's disease. Gut 58, 483-491.
100. Wu, N. L., Huang, D. Y., Hsieh, S. L., Hsiao, C. H., Lee, T. A., Lin, W. W. (2013) EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis. Biochim. Biophys. Acta 1832, 1538-1548.
101. Han, B., Bojalil, R., Amezcua-Guerra, L. M., Springall, R., Valderrama- Carvajal, H., Wu, J., Luo, H. (2008) DcR3 as a diagnostic parameter and risk factor for systemic lupus erythematosus. Int. Immunol. 20, 1067-1075.
102. Lee, C. S., Hu, C. Y., Tsai, H. F., Wu, C. S., Hsieh, S. L., Liu, L. C., Hsu, P. N. (2008) Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematosus. Clin. Exp. Immunol. 151, 383-390.
103. Liu, J., Zhao, Z., Zou, Y., Zhang, M., Zhou, Y., Li, Y., Pang, Z., Jin, W. (2015) The expression of death decoy receptor 3 was increased in the patients with primary Sjögren's syndrome. Clin. Rheumatol. 34, 879-885.
104. Kugathasan, S., Baldassano, R. N., Bradfield, J. P., Sleiman, P. M., Imielinski, M., Guthery, S. L., Cucchiara, S., Kim, C. E., Frackelton, E. C., Annaiah, K., Glessner, J. T., Santa, E., Willson, T., Eckert, A. W., Bonkowski, E., Shaner, J. L., Smith, R. M., Otieno, F. G., Peterson, N., Abrams, D. J., Chiavacci, R. M., Grundmeier, R., Mamula, P., Tomer, G., Piccoli, D. A., Monos, D. S., Annese, V., Denson, L. A., Grant, S. F., Hakonarson, H. (2008) Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat. Genet. 40, 1211-1215.
105. Haritunians, T., Taylor, K. D., Targan, S. R., Dubinsky, M., Ippoliti, A., Kwon, S., Guo, X., Melmed, G. Y., Berel, D., Mengesha, E., Psaty, B. M., Glazer, N. L., Vasiliauskas, E. A., Rotter, J. I., Fleshner, P. R., McGovern, D. P. (2010) Genetic predictors of medically refractory ulcerative colitis. Inflamm. Bowel Dis. 16, 1830-1840.
106. Picornell, Y., Mei, L., Taylor, K., Yang, H., Targan, S. R., Rotter, J. I. (2007) TNFSF15 is an ethnic-specific IBD gene. Inflamm. Bowel Dis. 13, 1333-1338.
107. Peter, I., Mitchell, A. A., Ozelius, L., Erazo, M., Hu, J., Doheny, D., Abreu, M. T., Present, D. H., Ullman, T., Benkov, K., Korelitz, B. I., Mayer, L., Desnick, R. J.; New York Crohn's Disease Working Group. (2011) Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study. BMC Med. Genet. 12, 63.
108. Kenny, E. E., Pe'er, I., Karban, A., Ozelius, L., Mitchell, A. A., Ng, S. M., Erazo, M., Ostrer, H., Abraham, C., Abreu, M. T., Atzmon, G., Barzilai, N., Brant, S. R., Bressman, S., Burns, E. R., Chowers, Y., Clark, L. N., Darvasi, A., Doheny, D., Duerr, R. H., Eliakim, R., Giladi, N., Gregersen, P. K., Hakonarson, H., Jones, M. R., Marder, K., McGovern, D. P., Mulle, J., Orr-Urtreger, A., Proctor, D. D., Pulver, A., Rotter, J. I., Silverberg, M. S., Ullman, T., Warren, S. T., Waterman, M., Zhang, W., Bergman, A., Mayer, L., Katz, S., Desnick, R. J., Cho, J. H., Peter, I. (2012) A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet. 8, e1002559.
109. Zucchelli, M., Camilleri, M., Andreasson, A. N., Bresso, F., Dlugosz, A., Halfvarson, J., Törkvist, L., Schmidt, P. T., Karling, P., Ohlsson, B., Duerr, R. H., Simren, M., Lindberg, G., Agreus, L., Carlson, P., Zinsmeister, A. R., D'Amato, M. (2011) Association of TNFSF15 polymorphism with irritable bowel syndrome. Gut 60, 1671-1677.
110. Cardinale, C. J., Wei, Z., Panossian, S., Wang, F., Kim, C. E., Mentch, F. D., Chiavacci, R. M., Kachelries, K. E., Pandey, R., Grant, S. F., Baldassano, R. N., Hakonarson, H. (2013) Targeted resequencing identifies defective variants of decoy receptor 3 in pediatric-onset inflammatory bowel disease. Genes Immun. 14, 447-452.
111. Mells, G. F., Floyd, J. A., Morley, K. I., Cordell, H. J., Franklin, C. S., Shin, S. Y., Heneghan, M. A., Neuberger, J. M., Donaldson, P. T., Day, D. B., Ducker, S. J., Muriithi, A. W., Wheater, E. F., Hammond, C. J., Dawwas, M. F., Jones, D. E., Peltonen, L., Alexander, G. J., Sandford, R. N., Anderson, C. A.; UK PBC Consortium; Wellcome Trust Case Control Consortium 3. (2011) Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat. Genet. 43, 329-332.
112. Cornélis, F., Fauré, S., Martinez, M., Prud'homme, J. F., Fritz, P., Dib, C., Alves, H., Barrera, P., de Vries, N., Balsa, A., Pascual-Salcedo, D., Maenaut, K., Westhovens, R., Migliorini, P., Tran, T. H., Delaye, A., Prince, N., Lefevre, C., Thomas, G., Poirier, M., Soubigou, S., Alibert, O., Lasbleiz, S., Fouix, S., Bouchier, C., Lioté, F., Loste, M. N., Lepage, V., Charron, D., Gyapay, G., Lopes-Vaz, A., Kuntz, D., Bardin, T., Weissenbach, J.; ECRAF. (1998) New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc. Natl. Acad. Sci. U. S. A. 95, 10746-10750.
113. Shiozawa, S., Hayashi, S., Tsukamoto, Y., Goko, H., Kawasaki, H., Wada, T., Shimizu, K., Yasuda, N., Kamatani, N., Takasugi, K., Tanaka, Y., Shiozawa, K., Imura, S. (1998) Identification of the gene loci that predispose to rheumatoid arthritis. Int. Immunol. 10, 1891-1895.
114. Osawa, K., Takami, N., Shiozawa, K., Hashiramoto, A., Shiozawa, S. (2004) Death receptor 3 (DR3) gene duplication in a chromosome region 1p36.3: gene duplication is more prevalent in rheumatoid arthritis. Genes Immun. 5, 439-443.
115. Orozco, G., Viatte, S., Bowes, J., Martin, P., Wilson, A. G., Morgan, A. W., Steer, S., Wordsworth, P., Hocking, L. J., Barton, A., Worthington, J., Eyre, S.; UK Rheumatoid Arthritis Genetics Consortium; Wellcome Trust Case Control Consortium; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate Consortium. (2014) Novel rheumatoid arthritis susceptibility locus at 22q12 identified in an extended UK genome-wide association study. Arthritis Rheumatol. 66, 24-30.
116. Stahl, E. A., Raychaudhuri, S., Remmers, E. F., Xie, G., Eyre, S., Thomson, B. P., Li, Y., Kurreeman, F. A., Zhernakova, A., Hinks, A., Guiducci, C., Chen, R., Alfredsson, L., Amos, C. I., Ardlie, K. G., Barton, A., Bowes, J., Brouwer, E., Burtt, N. P., Catanese, J. J., Coblyn, J., Coenen, M. J., Costenbader, K. H., Criswell, L. A., Crusius, J. B., Cui, J., de Bakker, P. I., De Jager, P. L., Ding, B., Emery, P., Flynn, E., Harrison, P., Hocking, L. J., Huizinga, T. W., Kastner, D. L., Ke, X., Lee, A. T., Liu, X., Martin, P., Morgan, A. W., Padyukov, L., Posthumus, M. D., Radstake, T. R., Reid, D. M., Seielstad, M., Seldin, M. F., Shadick, N. A., Steer, S., Tak, P. P., Thomson, W., van der Helm-van Mil, A. H., van der Horst-Bruinsma, I. E., van der Schoot, C. E., van Riel, P. L., Weinblatt, M. E., Wilson, A. G., Wolbink, G. J., Wordsworth, B. P., Wijmenga, C., Karlson, E. W., Toes, R. E., de Vries, N., Begovich, A. B., Worthington, J., Siminovitch, K. A., Gregersen, P. K., Klareskog, L., Plenge, R. M.; BIRAC Consortium; YEAR Consortium. (2010) Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 42, 508-514.
117. Jiang, L., Yin, J., Ye, L., Yang, J., Hemani, G., Liu, A. J., Zou, H., He, D., Sun, L., Zeng, X., Li, Z., Zheng, Y., Lin, Y., Liu, Y., Fang, Y., Xu, J., Li, Y., Dai, S., Guan, J., Jiang, L., Wei, Q., Wang, Y., Li, Y., Huang, C., Zuo, X., Liu, Y., Wu, X., Zhang, L., Zhou, L., Zhang, Q., Li, T., Chen, L., Xu, Z., Yang, X., Qian, F., Xie, W., Liu, W., Guo, Q., Huang, S., Zhao, J., Li, M., Jin, Y., Gao, J., Lv, Y., Wang, Y., Lin, L., Guo, A., Danoy, P., Willner, D., Cremin, C., Hadler, J., Zhang, F., Zhao, Y., Li, M., Yue, T., Fan, X., Guo, J., Mu, R., Li, J., Wu, C., Zeng, M., Wang, J., Li, S., Jin, L., Wang, B., Wang, J., Ma, X., Sun, L., Zhang, X., Brown, M. A., Visscher, P. M., Su, D. F., Xu, H. (2014) Novel risk loci for rheumatoid arthritis in Han Chinese and congruence with risk variants in Europeans. Arthritis Rheumatol. 66, 1121-1132.
118. Zhang, F., Liu, H., Chen, S., Low, H., Sun, L., Cui, Y., Chu, T., Li, Y., Fu, X., Yu, Y., Yu, G., Shi, B., Tian, H., Liu, D., Yu, X., Li, J., Lu, N., Bao, F., Yuan, C., Liu, J., Liu, H., Zhang, L., Sun, Y., Chen, M., Yang, Q., Yang, H., Yang, R., Zhang, L., Wang, Q., Liu, H., Zuo, F., Zhang, H., Khor, C. C., Hibberd, M. L., Yang, S., Liu, J., Zhang, X. (2011) Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy. Nat. Genet. 43, 1247-1251.
119. Zhang, F. R., Huang, W., Chen, S. M., Sun, L. D., Liu, H., Li, Y., Cui, Y., Yan, X. X., Yang, H. T., Yang, R. D., Chu, T. S., Zhang, C., Zhang, L., Han, J. W., Yu, G. Q., Quan, C., Yu, Y. X., Zhang, Z., Shi, B. Q., Zhang, L. H., Cheng, H., Wang, C. Y., Lin, Y., Zheng, H. F., Fu, X. A., Zuo, X. B., Wang, Q., Long, H., Sun, Y. P., Cheng, Y. L., Tian, H. Q., Zhou, F. S., Liu, H. X., Lu, W. S., He, S. M., Du, W. L., Shen, M., Jin, Q. Y., Wang, Y., Low, H. Q., Erwin, T., Yang, N. H., Li, J. Y., Zhao, X., Jiao, Y. L., Mao, L. G., Yin, G., Jiang, Z. X., Wang, X. D., Yu, J. P., Hu, Z. H., Gong, C. H., Liu, Y. Q., Liu, R. Y., Wang, D. M., Wei, D., Liu, J. X., Cao, W. K., Cao, H. Z., Li, Y. P., Yan, W. G., Wei, S. Y., Wang, K. J., Hibberd, M. L., Yang, S., Zhang, X. J., Liu, J. J. (2009) Genomewide association study of leprosy. N. Engl. J. Med. 361, 2609-2618.
120. Grant, A. V., Alter, A., Huong, N. T., Orlova, M., Van Thuc, N., Ba, N. N., Thai, V. H., Abel, L., Schurr, E., Alcais, A. (2012) Crohn's disease susceptibility genes are associated with leprosy in the Vietnamese population. J. Infect. Dis. 206, 1763-1767.
121. Wong, S. H., Hill, A. V., Vannberg, F. O.; India-Africa-United Kingdom Leprosy Genetics Consortium. (2010) Genomewide association study of leprosy. N. Engl. J. Med. 362, 1446-1447.
122. Fava, V. M., Cobat, A., Van Thuc, N., Latini, A. C., Stefani, M. M., Belone, A. F., Ba, N. N., Orlova, M., Manry, J., Mira, M. T., Thai, V. H., Abel, L., Alcaïs, A., Schurr, E. (2015) Association of TNFSF8 regulatory variants with excessive inflammatory responses but not leprosy per se. J. Infect. Dis. 211, 968-977.
123. Michelsen, K. S., Thomas, L. S., Taylor, K. D., Yu, Q. T., Mei, L., Landers, C. J., Derkowski, C., McGovern, D. P., Rotter, J. I., Targan, S. R. (2009) IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein. PLoS One 4, e4719.
124. Kakuta, Y., Ueki, N., Kinouchi, Y., Negoro, K., Endo, K., Nomura, E., Takagi, S., Takahashi, S., Shimosegawa, T. (2009) TNFSF15 transcripts from risk haplotype for Crohn's disease are overexpressed in stimulated T cells. Hum. Mol. Genet. 18, 1089-1098.
125. Raj, T., Rothamel, K., Mostafavi, S., Ye, C., Lee, M. N., Replogle, J. M., Feng, T., Lee, M., Asinovski, N., Frohlich, I., Imboywa, S., Von Korff, A., Okada, Y., Patsopoulos, N. A., Davis, S., McCabe, C., Paik, H. I., Srivastava, G. P., Raychaudhuri, S., Hafler, D. A., Koller, D., Regev, A., Hacohen, N., Mathis, D., Benoist, C., Stranger, B. E., De Jager, P. L. (2014) Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science 344, 519-523.
126. Lee, M. N., Ye, C., Villani, A. C., Raj, T., Li, W., Eisenhaure, T. M., Imboywa, S. H., Chipendo, P. I., Ran, F. A., Slowikowski, K., Ward, L. D., Raddassi, K., McCabe, C., Lee, M. H., Frohlich, I. Y., Hafler, D. A., Kellis, M., Raychaudhuri, S., Zhang, F., Stranger, B. E., Benoist, C. O., De Jager, P. L., Regev, A., Hacohen, N. (2014) Common genetic variants modulate pathogen-sensing responses in human dendritic cells. Science 343, 1246980.
127. Sfikakis, P. P. (2010) The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Curr. Dir. Autoimmun. 11, 180-210.